Nasila UK Ltd is a UK-based pharma company specialising in obtaining Marketing Authorisations for certain niche generics with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA)& European Regulatory Authority. Our ethos is to provide the highest quality generic drugs to our target markets. To achieve this, we only use generic Contract Manufacturers based in the UK or Western Europe to manufacture our products, or for our respiratory range, outside of Europe, but at a site that is US FDA, UK MHRA and GCC GMP Certified, and this, only after we have carried out a thorough due-diligence process. Our products are sold mainly in the UK, Western Europe and The Cooperation Council for the Arab States of the Gulf, originally known as the Gulf Cooperation Council (GCC).
We are an ambitious and a progressive company. From small beginnings, the number of our Marketing Authorisations has steadily grown as has the disease states within which our products fall. We aim to forge ahead and continually build on our success to date.
Additionally, we are an open-minded company, ready to listen to innovative ideas. We also welcome enquiries from UK and Western European generic Contract Manufacturers who own Marketing Authorisations and with whom we could collaborate.